These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15102545)

  • 1. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic metabolism in the zebrafish: a review of the spatiotemporal distribution, modulation and activity of Cytochrome P450 families 1 to 3.
    Saad M; Cavanaugh K; Verbueken E; Pype C; Casteleyn C; Van Ginneken C; Van Cruchten S
    J Toxicol Sci; 2016 Feb; 41(1):1-11. PubMed ID: 26763387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid regulation of drug-metabolizing cytochromes P450.
    Monostory K; Dvorak Z
    Curr Drug Metab; 2011 Feb; 12(2):154-72. PubMed ID: 21395541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of coumarin by human P450s: a molecular modelling study.
    Lewis DF; Ito Y; Lake BG
    Toxicol In Vitro; 2006 Mar; 20(2):256-64. PubMed ID: 16157466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450-mediated metabolism in brain: functional roles and their implications.
    Ravindranath V; Strobel HW
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):551-8. PubMed ID: 23330950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling human cytochromes P450 for evaluating drug metabolism: an update.
    Lewis DF
    Drug Metabol Drug Interact; 2000; 16(4):307-24. PubMed ID: 11201309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 (CYP) in fish.
    Uno T; Ishizuka M; Itakura T
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):1-13. PubMed ID: 22418068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.
    Waxman DJ
    Arch Biochem Biophys; 1999 Sep; 369(1):11-23. PubMed ID: 10462436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-dependent metabolism of xenobiotics.
    Mugford CA; Kedderis GL
    Drug Metab Rev; 1998 Aug; 30(3):441-98. PubMed ID: 9710703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.